<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="8.9 years [range, 1–18 years]; 165 females). Majority had functional" exact="constipation" post="(35.4%), followed by functional abdominal pain (30.6%), irritable bowel"/>
 <result pre="had functional constipation (35.4%), followed by functional abdominal pain (30.6%)," exact="irritable bowel syndrome" post="(17.0%), functional dyspepsia (12.6%), functional nausea (3.4%) and abdominal"/>
 <result pre="by functional abdominal pain (30.6%), irritable bowel syndrome (17.0%), functional" exact="dyspepsia" post="(12.6%), functional nausea (3.4%) and abdominal migraine (1.0%). Regression"/>
 <result pre="syndrome (17.0%), functional dyspepsia (12.6%), functional nausea (3.4%) and abdominal" exact="migraine" post="(1.0%). Regression model found that only significant factor associated"/>
 <result pre="vomiting) at diagnosis. Furthermore, in pain symptoms (functional abdominal pain," exact="irritable bowel syndrome," post="dyspepsia) no treatment positively correlated with pain improvement. Conclusion"/>
 <result pre="male and 165 (56.1%) were female. Most prevalent FGIDs were" exact="constipation" post="and functional abdominal pain (FAP), distribution is presented in"/>
 <result pre="complaint or the type of functional disorder. Thus, patients with" exact="constipation" post="received laxatives and fibers, while pain predominant disorders (FAP"/>
 <result pre="received laxatives and fibers, while pain predominant disorders (FAP and" exact="irritable bowel syndrome" post="[IBS]) received different type of therapy. In patients with"/>
 <result pre="syndrome [IBS]) received different type of therapy. In patients with" exact="dyspepsia" post="majority received ranitidine. Due to differences in the symptoms"/>
 <result pre="at diagnosis ( p=0.763). In pain disorders (FAP, IBS, functional" exact="dyspepsia" post="and abdominal migraine) no treatment positively correlated with pain"/>
 <result pre="migraine. Similarly, certain European studies estimated the prevalence of functional" exact="constipation" post="to be highest, ranging from 6% to even 52.7%,"/>
 <result pre="by FAP with frequency of 10.2–53.8%, IBS of 10.3–43%, functional" exact="dyspepsia" post="of 7–13.4%, and abdominal migraine of 4–23% [ 10"/>
 <result pre="10.2–53.8%, IBS of 10.3–43%, functional dyspepsia of 7–13.4%, and abdominal" exact="migraine" post="of 4–23% [ 10 11 12 13]. Comparison and"/>
 <result pre="(e.g,. presence of persistent vomiting in patients suffering from abdominal" exact="migraine" post="or functional nausea) or could be otherwise explained in"/>
 <result pre="due to feeling of discomfort in patients suffering from functional" exact="dyspepsia" post="and IBS). Although alarm symptoms still hold a great"/>
 <result pre="for pediatric patients exists solely for those suffering from functional" exact="constipation" post="[ 17]. To this day, incomplete pathophysiological understanding of"/>
 <result pre="and improvement of symptoms was the highest amongst children with" exact="constipation" post="(83.7%) and the lowest rates were found amongst children"/>
 <result pre="the lowest rates were found amongst children diagnosed with abdominal" exact="migraine" post="(33.3%). No significant difference in improvement of symptoms between"/>
 <result pre="drive diagnostic costs for children with functional abdominal pain and" exact="irritable bowel syndrome" post="in primary or tertiary care Pediatrics 2009 123 758"/>
 <result pre="MW Nurko S et al. Evaluation and treatment of functional" exact="constipation" post="in infants and children: evidence-based recommendations from ESPGHAN and"/>
 <result pre="the different functional gastrointestinal disorders. FAP: functional abdominal pain, IBS:" exact="irritable bowel syndrome." post="Table 1 Differences in Age and Anthropometrics between Diagnoses"/>
 <result pre="median (range) or numer (%). FAP: functional abdominal pain, IBS:" exact="irritable bowel syndrome." post="*Post-hoc analysis (Bonferroni) not significant for intergroup analysis. Table"/>
 <result pre="are presented as numer (%). FAP: functional abdominal pain, IBS:" exact="irritable bowel syndrome." post="Table 3 Prognostic Factors for Symptom Improvement Binary logistic"/>
</results>
